Evolus Inc buy stratec
Start price
20.05.19
/
50%
€14.97
Target price
24.10.20
€8.00
Performance (%)
-81.26%
End price
24.10.20
€2.81
Summary
This prediction ended on 24.10.20 with a price of €2.81. The BUY prediction by stratec for Evolus Inc performed very badly with a performance of -81.26%. stratec has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Evolus Inc | 1.648% | 1.648% | -36.775% | -23.940% |
| iShares Core DAX® | 0.855% | 0.389% | 2.533% | 52.003% |
| iShares Nasdaq 100 | -0.989% | -4.400% | 25.154% | 77.536% |
| iShares Nikkei 225® | -1.781% | -11.216% | 44.398% | 64.676% |
| iShares S&P 500 | 0.057% | 0.778% | 20.953% | 63.009% |
Comments by stratec for this prediction
In the thread Evolus Inc diskutieren
stratec stimmt der Buy-Einschätzung von klostergang zu
stratec stimmt am 20.05.2019 der Buy-Einschätzung von klostergang mit dem Kursziel 35$ zu.
Überschrift: Evolus obtained FDA approval for its product Jeuveau to treat patients with glabellar lines.
Es gibt keinen Handelsplatz
Kursziel geändert auf 8,0